Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,6867,70,89
Msft-1,27
Nokia3,3183,34953,52
IBM0,06
Mercedes-Benz Group AG74,0874,1-0,90
PFE2,40
20.04.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 19.04.2024
Curaleaf Hldg Rg (US Other OTC (Pink Sheets))
Závěr k 19.4.2024 Změna (%) Změna (USD) Objem obchodů (ks)
4,94 -2,56 -0,13 326 848
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 20.04.2024
Popis společnosti
Obecné informace
Název společnostiCuraleaf Holdings Inc
TickerCURA
Kmenové akcie:Ordinary Shares Subordinate Voting
Kmenové akcie:Ordinary Shares Multiple Voting
RICCURA.TO
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 5 650
Akcie v oběhu k 15.03.2024 736 511 072
MěnaUSD
Kontaktní informace
Ulice420 Lexington Avenue
MěstoNEW YORK
PSČ10170
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 814 510 117

Business Summary: Curaleaf Holdings, Inc. is an international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, and Grassroots provide service, product selection and accessibility across the medical and adult-use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. Curaleaf International is an integrated cannabis company in Europe with a supply and distribution network throughout the European market. It also offers Can4Med, a pharmaceutical wholesaler specializing in cannabinoid medications in Poland. Curaleaf is the national retail dispensary brand in the United States and a mainstream cannabis brand available in multiple states and product formats: vape oils and concentrates, flower, pre rolls and flower pod, topical lotions, capsules and tinctures, mints and lozenges and edibles.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Curaleaf Holdings Inc revenues increased 6% to $1.35B. Net loss before extraordinary items decreased 11% to $229.8M. Revenues reflect Management fee income increase of 21% to $5.9M. Lower net loss reflects Loss on impairment decrease of 19% to $67.1M (expense), Share-based compensation decrease of 29% to $20M (expense), Other income - Balancing value increase from $1.8M (expense) to $4.6M (income).
Odvětvová klasifikace
TRBC2012Recreational Pharmaceuticals
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS1997Medicinal and Botanical Manufacturing
SICPharmaceutical Preparations



  • Poslední aktualizace: 20.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardBoris Jordan56
President, Chief Executive OfficerMatt Darin4309.05.202204.01.2022
Executive Vice Chairman of the BoardJoseph Lusardi4901.01.2021
Chief Financial OfficerEdward Kremer5008.08.202208.08.2022
Chief People OfficerTyneeha Rivers4524.05.202224.05.2022
Chief Investment OfficerCamilo Lyon4708.08.202208.08.2022
Chief Compliance OfficerJames Shorris62
Chief Legal OfficerPeter Clateman55
Chief Strategy OfficerMitch Hara5803.08.202203.08.2022